PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128206
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128206
Generative AI in Life Sciences Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of Generative AI in Life Sciences Market
The global Generative AI in Life Sciences Market is witnessing remarkable growth as pharmaceutical companies, biotechnology firms, and research organizations increasingly adopt artificial intelligence to accelerate drug discovery, streamline clinical trials, enhance regulatory documentation, and improve scientific decision-making. According to the report, the global Generative AI in Life Sciences Market was valued at USD 1.18 billion in 2025. The market is projected to grow from USD 1.60 billion in 2026 to USD 18.20 billion by 2034, exhibiting a CAGR of 35.52% during the forecast period. In 2025, North America dominated the market with a 46.61% share, supported by advanced healthcare infrastructure, strong pharmaceutical R&D investments, and rapid adoption of AI-powered drug development platforms.
Generative AI in life sciences includes AI-powered software, platforms, and models that generate scientific insights, automate documentation, optimize molecular design, and support data-driven decision-making across the pharmaceutical and biotechnology industries.
Market Definition and Scope
Generative AI is transforming life sciences by enabling organizations to process vast volumes of genomic, molecular, imaging, regulatory, and clinical data efficiently. These AI solutions assist researchers in identifying drug candidates, designing clinical trials, generating regulatory documents, summarizing scientific literature, and improving knowledge management.
The market covers software platforms, AI services, cloud-based and on-premise deployments, large language models (LLMs), natural language processing technologies, generative molecular models, and machine learning applications. Its scope extends across pharmaceutical & biotechnology companies, contract research organizations (CROs), research institutes, diagnostics companies, and other healthcare organizations seeking faster and more efficient research workflows.
Market Dynamics
Drivers
The growing volume of genomic, molecular, and clinical data is one of the primary factors driving market expansion. Traditional analytical methods often struggle to process increasingly complex datasets, whereas generative AI enables rapid data interpretation, target identification, molecule generation, and optimized clinical trial planning. Pharmaceutical companies are adopting AI platforms to reduce development costs, accelerate research timelines, and improve success rates.
Trends
A key market trend is the rising adoption of AI copilots across life sciences research. These intelligent assistants help scientists summarize research findings, compare experimental data, generate reports, and retrieve scientific knowledge from multiple data sources. Companies are increasingly integrating AI copilots directly into laboratory and research workflows, improving productivity while reducing manual documentation efforts.
Restraints
Regulatory uncertainty remains a significant restraint for market growth. Healthcare regulators require AI-generated outputs to be transparent, validated, explainable, and fully traceable before being used in scientific or regulatory submissions. Concerns regarding AI hallucinations, inaccurate outputs, and compliance issues continue to limit the adoption of fully autonomous AI systems.
Opportunities
Growing use of generative AI in real-world evidence (RWE) and pharmacovigilance presents significant growth opportunities. AI-powered platforms help pharmaceutical companies analyze patient records, adverse event reports, and post-market surveillance data, enabling faster safety monitoring and improved evidence generation.
Segmentation Analysis
By component, software and platforms dominate the market due to increasing demand for scalable AI infrastructure supporting drug discovery, scientific research, and enterprise knowledge management. Services are expected to witness strong growth as organizations seek implementation, consulting, and integration support.
By deployment, cloud-based solutions hold the largest market share because they provide scalable computing resources, secure collaboration, continuous AI model updates, and easier integration across research organizations.
By technology, Large Language Models (LLMs) dominate the market owing to their extensive use in medical writing, regulatory documentation, literature reviews, clinical protocol development, and scientific content generation.
By product type, standalone solutions lead the market as pharmaceutical companies prefer testing dedicated AI applications before integrating them into enterprise-wide research systems.
By application, drug discovery and design account for the largest share due to heavy investments in AI-enabled molecule generation, target identification, and biologics research. By end user, pharmaceutical and biotechnology companies remain the leading adopters as they possess the resources and data necessary for large-scale AI implementation.
Regional Insights
North America leads the global market with a valuation of USD 0.55 billion in 2025, driven by strong AI adoption, advanced cloud infrastructure, and substantial pharmaceutical research investments. Europe remains the second-largest market due to increasing adoption of responsible AI technologies and regulatory compliance initiatives. Asia Pacific is emerging rapidly with growing biotechnology investments, expanding pharmaceutical manufacturing, and accelerating healthcare digitalization. Latin America and the Middle East & Africa are expected to witness steady growth as healthcare organizations increasingly adopt AI-enabled research and clinical solutions.
Competitive Landscape
The market is moderately fragmented, with leading companies focusing on AI innovation, strategic collaborations, and product development. Major players include NVIDIA Corporation, Oracle Corporation, Microsoft Corporation, IQVIA Inc., Veeva Systems Inc., Alphabet Inc., Benchling Inc., Insilico Medicine, Recursion Pharmaceuticals, and Tempus AI. These companies continue investing in scientific AI models, enterprise cloud platforms, and AI-powered drug discovery technologies to strengthen their competitive position.
Report Coverage
The report provides a comprehensive analysis of the global Generative AI in Life Sciences Market, including market size for 2025, 2026, and 2034, market dynamics, growth drivers, emerging trends, restraints, opportunities, segmentation by component, deployment, technology, product type, application, and end user. It also includes regional analysis, competitive landscape, company profiles, and recent industry developments shaping the future of the market.
Conclusion
The global Generative AI in Life Sciences Market is poised for exceptional expansion, growing from USD 1.18 billion in 2025 to USD 1.60 billion in 2026, and reaching USD 18.20 billion by 2034. Rising adoption of AI-powered drug discovery platforms, increasing pharmaceutical R&D investments, rapid digital transformation, and growing demand for efficient scientific workflows will continue driving market growth. Despite regulatory and integration challenges, continuous technological advancements and expanding AI applications across life sciences are expected to create significant long-term opportunities for market participants.
Segmentation By Component, Deployment, Technology, Product Type, Application, End User, and Region
By Component * Software/Platforms
- Services
By Deployment * Cloud-Based
- On-Premise
- Hybrid
By Technology * Large Language Models (LLMs)
- Natural Language Processing (NLP)
- Generative Molecular/Protein Models
- Machine Learning & Deep Learning
- Others
By Product Type * Standalone
- Integrated
By Application * Drug Discovery & Design
- Clinical Trial Design & Operations
- Regulatory Writing & Submissions
- Medical Affairs & Scientific Content
- Pharmacovigilance
- Commercial & Market Access Content
- Others
By End User * Pharmaceutical & Biotechnology Companies
- CROs
- Academic & Research Institutes
- MedTech/Diagnostics Companies
- Others
By Region * North America (By Component, Deployment, Technology, Product Type, Application, End User, and Country)
- U.S.
- Canada
- Europe (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Challenges
- 3.5. Market Trends
4. Key Insights
- 4.1. Overview of Technological Advancements
- 4.2. New Product Launches, By Key Players
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
- 4.4. Key Start Ups, By Regions/Countries
5. Global Generative AI in Life Sciences Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Component
- 5.1.1. Software/Platforms
- 5.1.2. Services
- 5.2. Market Analysis, Insights and Forecast - By Deployment
- 5.2.1. Cloud-Based
- 5.2.2. On-Premise
- 5.2.3. Hybrid
- 5.3. Market Analysis, Insights and Forecast - By Technology
- 5.3.1. Large Language Models (LLMs)
- 5.3.2. Natural Language Processing (NLP)
- 5.3.3. Generative Molecular/Protein Models
- 5.3.4. Machine Learning & Deep Learning
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast - By Product Type
- 5.4.1. Standalone
- 5.4.2. Integrated
- 5.5. Market Analysis, Insights and Forecast - By Application
- 5.5.1. Drug Discovery & Design
- 5.5.2. Clinical Trial Design & Operations
- 5.5.3. Regulatory Writing & Submissions
- 5.5.4. Medical Affairs & Scientific Content
- 5.5.5. Pharmacovigilance
- 5.5.6. Commercial & Market Access Content
- 5.5.7. Others
- 5.6. Market Analysis, Insights and Forecast - By End User
- 5.6.1. Pharmaceutical & Biotechnology Companies
- 5.6.2. CROs
- 5.6.3. Academic & Research Institutes
- 5.6.4. MedTech/Diagnostics Companies
- 5.6.5. Others
- 5.7. Market Analysis, Insights and Forecast - Region
- 5.7.1. North America
- 5.7.2. Europe
- 5.7.3. Asia Pacific
- 5.7.4. Latin America
- 5.7.5. Middle East & Africa
6. North America Generative AI in Life Sciences Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Component
- 6.1.1. Software/Platforms
- 6.1.2. Services
- 6.2. Market Analysis, Insights and Forecast - By Deployment
- 6.2.1. Cloud-Based
- 6.2.2. On-Premise
- 6.2.3. Hybrid
- 6.3. Market Analysis, Insights and Forecast - By Technology
- 6.3.1. Large Language Models (LLMs)
- 6.3.2. Natural Language Processing (NLP)
- 6.3.3. Generative Molecular/Protein Models
- 6.3.4. Machine Learning & Deep Learning
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast - By Product Type
- 6.4.1. Standalone
- 6.4.2. Integrated
- 6.5. Market Analysis, Insights and Forecast - By Application
- 6.5.1. Drug Discovery & Design
- 6.5.2. Clinical Trial Design & Operations
- 6.5.3. Regulatory Writing & Submissions
- 6.5.4. Medical Affairs & Scientific Content
- 6.5.5. Pharmacovigilance
- 6.5.6. Commercial & Market Access Content
- 6.5.7. Others
- 6.6. Market Analysis, Insights and Forecast - By End User
- 6.6.1. Pharmaceutical & Biotechnology Companies
- 6.6.2. CROs
- 6.6.3. Academic & Research Institutes
- 6.6.4. MedTech/Diagnostics Companies
- 6.6.5. Others
- 6.7. Market Analysis, Insights and Forecast - By Country
- 6.7.1. U.S.
- 6.7.2. Canada
7. Europe Generative AI in Life Sciences Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Component
- 7.1.1. Software/Platforms
- 7.1.2. Services
- 7.2. Market Analysis, Insights and Forecast - By Deployment
- 7.2.1. Cloud-Based
- 7.2.2. On-Premise
- 7.2.3. Hybrid
- 7.3. Market Analysis, Insights and Forecast - By Technology
- 7.3.1. Large Language Models (LLMs)
- 7.3.2. Natural Language Processing (NLP)
- 7.3.3. Generative Molecular/Protein Models
- 7.3.4. Machine Learning & Deep Learning
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast - By Product Type
- 7.4.1. Standalone
- 7.4.2. Integrated
- 7.5. Market Analysis, Insights and Forecast - By Application
- 7.5.1. Drug Discovery & Design
- 7.5.2. Clinical Trial Design & Operations
- 7.5.3. Regulatory Writing & Submissions
- 7.5.4. Medical Affairs & Scientific Content
- 7.5.5. Pharmacovigilance
- 7.5.6. Commercial & Market Access Content
- 7.5.7. Others
- 7.6. Market Analysis, Insights and Forecast - By End User
- 7.6.1. Pharmaceutical & Biotechnology Companies
- 7.6.2. CROs
- 7.6.3. Academic & Research Institutes
- 7.6.4. MedTech/Diagnostics Companies
- 7.6.5. Others
- 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.7.1. U.K.
- 7.7.2. Germany
- 7.7.3. France
- 7.7.4. Italy
- 7.7.5. Spain
- 7.7.6. Scandinavia
- 7.7.7. Rest of Europe
8. Asia Pacific Generative AI in Life Sciences Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Component
- 8.1.1. Software/Platforms
- 8.1.2. Services
- 8.2. Market Analysis, Insights and Forecast - By Deployment
- 8.2.1. Cloud-Based
- 8.2.2. On-Premise
- 8.2.3. Hybrid
- 8.3. Market Analysis, Insights and Forecast - By Technology
- 8.3.1. Large Language Models (LLMs)
- 8.3.2. Natural Language Processing (NLP)
- 8.3.3. Generative Molecular/Protein Models
- 8.3.4. Machine Learning & Deep Learning
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast - By Product Type
- 8.4.1. Standalone
- 8.4.2. Integrated
- 8.5. Market Analysis, Insights and Forecast - By Application
- 8.5.1. Drug Discovery & Design
- 8.5.2. Clinical Trial Design & Operations
- 8.5.3. Regulatory Writing & Submissions
- 8.5.4. Medical Affairs & Scientific Content
- 8.5.5. Pharmacovigilance
- 8.5.6. Commercial & Market Access Content
- 8.5.7. Others
- 8.6. Market Analysis, Insights and Forecast - By End User
- 8.6.1. Pharmaceutical & Biotechnology Companies
- 8.6.2. CROs
- 8.6.3. Academic & Research Institutes
- 8.6.4. MedTech/Diagnostics Companies
- 8.6.5. Others
- 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.7.1. China
- 8.7.2. Japan
- 8.7.3. India
- 8.7.4. Southeast Asia
- 8.7.5. Australia
- 8.7.6. Rest of Asia Pacific
9. Latin America Generative AI in Life Sciences Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Component
- 9.1.1. Software/Platforms
- 9.1.2. Services
- 9.2. Market Analysis, Insights and Forecast - By Deployment
- 9.2.1. Cloud-Based
- 9.2.2. On-Premise
- 9.2.3. Hybrid
- 9.3. Market Analysis, Insights and Forecast - By Technology
- 9.3.1. Large Language Models (LLMs)
- 9.3.2. Natural Language Processing (NLP)
- 9.3.3. Generative Molecular/Protein Models
- 9.3.4. Machine Learning & Deep Learning
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast - By Product Type
- 9.4.1. Standalone
- 9.4.2. Integrated
- 9.5. Market Analysis, Insights and Forecast - By Application
- 9.5.1. Drug Discovery & Design
- 9.5.2. Clinical Trial Design & Operations
- 9.5.3. Regulatory Writing & Submissions
- 9.5.4. Medical Affairs & Scientific Content
- 9.5.5. Pharmacovigilance
- 9.5.6. Commercial & Market Access Content
- 9.5.7. Others
- 9.6. Market Analysis, Insights and Forecast - By End User
- 9.6.1. Pharmaceutical & Biotechnology Companies
- 9.6.2. CROs
- 9.6.3. Academic & Research Institutes
- 9.6.4. MedTech/Diagnostics Companies
- 9.6.5. Others
- 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.7.1. Brazil
- 9.7.2. Mexico
- 9.7.3. Rest of Latin America
10. Middle East & Africa Generative AI in Life Sciences Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Component
- 10.1.1. Software/Platforms
- 10.1.2. Services
- 10.2. Market Analysis, Insights and Forecast - By Deployment
- 10.2.1. Cloud-Based
- 10.2.2. On-Premise
- 10.2.3. Hybrid
- 10.3. Market Analysis, Insights and Forecast - By Technology
- 10.3.1. Large Language Models (LLMs)
- 10.3.2. Natural Language Processing (NLP)
- 10.3.3. Generative Molecular/Protein Models
- 10.3.4. Machine Learning & Deep Learning
- 10.3.5. Others
- 10.4. Market Analysis, Insights and Forecast - By Product Type
- 10.4.1. Standalone
- 10.4.2. Integrated
- 10.5. Market Analysis, Insights and Forecast - By Application
- 10.5.1. Drug Discovery & Design
- 10.5.2. Clinical Trial Design & Operations
- 10.5.3. Regulatory Writing & Submissions
- 10.5.4. Medical Affairs & Scientific Content
- 10.5.5. Pharmacovigilance
- 10.5.6. Commercial & Market Access Content
- 10.5.7. Others
- 10.6. Market Analysis, Insights and Forecast - By End User
- 10.6.1. Pharmaceutical & Biotechnology Companies
- 10.6.2. CROs
- 10.6.3. Academic & Research Institutes
- 10.6.4. MedTech/Diagnostics Companies
- 10.6.5. Others
- 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.7.1. GCC
- 10.7.2. South Africa
- 10.7.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. NVIDIA Corporation
- 11.2.2. IQVIA Inc.
- 11.2.3. Oracle Corporation
- 11.2.4. Veeva Systems Inc.
- 11.2.5. Microsoft Corporation
- 11.2.6. Alphabet Inc.
- 11.2.7. Benchling, Inc.
- 11.2.8. Insilico Medicine
- 11.2.9. Recursion Pharmaceuticals, Inc.
- 11.2.10. Tempus AI, Inc.
List of Tables
- Table 1: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Component, 2021-2034
- Table 2: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
- Table 3: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Technology 2021-2034
- Table 4: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 5: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 6: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 7: Global Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 8: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Component, 2021-2034
- Table 9: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
- Table 10: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Technology 2021-2034
- Table 11: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 12: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 13: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 14: North America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Country, 2021-2034
- Table 15: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Component, 2021-2034
- Table 16: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
- Table 17: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Technology 2021-2034
- Table 18: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 19: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 20: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 21: Europe Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 22: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Component, 2021-2034
- Table 23: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
- Table 24: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Technology 2021-2034
- Table 25: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 26: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 27: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 28: Asia Pacific Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 29: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Component, 2021-2034
- Table 30: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
- Table 31: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Technology 2021-2034
- Table 32: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 33: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 34: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 35: Latin America Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 36: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Component, 2021-2034
- Table 37: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
- Table 38: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Technology 2021-2034
- Table 39: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
- Table 40: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 41: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by End User, 2021-2034
- Table 42: Middle East & Africa Generative AI In Life Sciences Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Generative AI In Life Sciences Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Generative AI In Life Sciences Market Value Share (%), by Component, 2025 & 2034
- Figure 3: Global Generative AI In Life Sciences Market Value Share (%), by Deployment, 2025 & 2034
- Figure 4: Global Generative AI In Life Sciences Market Value Share (%), by Technology, 2025 & 2034
- Figure 5: Global Generative AI In Life Sciences Market Value Share (%), by Product Type, 2025 & 2034
- Figure 6: Global Generative AI In Life Sciences Market Value Share (%), by Application, 2025 & 2034
- Figure 7: Global Generative AI In Life Sciences Market Value Share (%), by End User, 2025 & 2034
- Figure 8: Global Generative AI In Life Sciences Market Value Share (%), by Region, 2025 & 2034
- Figure 9: North America Generative AI In Life Sciences Market Value (USD billion), by Component, 2025 & 2034
- Figure 10: North America Generative AI In Life Sciences Market Value Share (%), by Component, 2025
- Figure 11: North America Generative AI In Life Sciences Market Value (USD billion), by Deployment, 2025 & 2034
- Figure 12: North America Generative AI In Life Sciences Market Value Share (%), by Deployment, 2025
- Figure 13: North America Generative AI In Life Sciences Market Value (USD billion), by Technology 2025 & 2034
- Figure 14: North America Generative AI In Life Sciences Market Value Share (%), by Technology 2025
- Figure 15: North America Generative AI In Life Sciences Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 16: North America Generative AI In Life Sciences Market Value Share (%), by Product Type, 2025
- Figure 17: North America Generative AI In Life Sciences Market Value (USD billion), by Application, 2025 & 2034
- Figure 18: North America Generative AI In Life Sciences Market Value Share (%), by Application, 2025
- Figure 19: North America Generative AI In Life Sciences Market Value (USD billion), by End User, 2025 & 2034
- Figure 20: North America Generative AI In Life Sciences Market Value Share (%), by End User, 2025
- Figure 21: North America Generative AI In Life Sciences Market Value (USD billion), by Country, 2025 & 2034
- Figure 22: North America Generative AI In Life Sciences Market Value Share (%), by Country, 2025
- Figure 23: Europe Generative AI In Life Sciences Market Value (USD billion), by Component, 2025 & 2034
- Figure 24: Europe Generative AI In Life Sciences Market Value Share (%), by Component, 2025
- Figure 25: Europe Generative AI In Life Sciences Market Value (USD billion), by Deployment, 2025 & 2034
- Figure 26: Europe Generative AI In Life Sciences Market Value Share (%), by Deployment, 2025
- Figure 27: Europe Generative AI In Life Sciences Market Value (USD billion), by Technology 2025 & 2034
- Figure 28: Europe Generative AI In Life Sciences Market Value Share (%), by Technology 2025
- Figure 29: Europe Generative AI In Life Sciences Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 30: Europe Generative AI In Life Sciences Market Value Share (%), by Product Type, 2025
- Figure 31: Europe Generative AI In Life Sciences Market Value (USD billion), by Application, 2025 & 2034
- Figure 32: Europe Generative AI In Life Sciences Market Value Share (%), by Application, 2025
- Figure 33: Europe Generative AI In Life Sciences Market Value (USD billion), by End User, 2025 & 2034
- Figure 34: Europe Generative AI In Life Sciences Market Value Share (%), by End User, 2025
- Figure 35: Europe Generative AI In Life Sciences Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 36: Europe Generative AI In Life Sciences Market Value Share (%), by Country/ Sub-region, 2025
- Figure 37: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by Component, 2025 & 2034
- Figure 38: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by Component, 2025
- Figure 39: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by Deployment, 2025 & 2034
- Figure 40: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by Deployment, 2025
- Figure 41: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by Technology 2025 & 2034
- Figure 42: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by Technology 2025
- Figure 43: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 44: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by Product Type, 2025
- Figure 45: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by Application, 2025 & 2034
- Figure 46: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by Application, 2025
- Figure 47: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by End User, 2025 & 2034
- Figure 48: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by End User, 2025
- Figure 49: Asia Pacific Generative AI In Life Sciences Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 50: Asia Pacific Generative AI In Life Sciences Market Value Share (%), by Country/ Sub-region, 2025
- Figure 51: Latin America Generative AI In Life Sciences Market Value (USD billion), by Component, 2025 & 2034
- Figure 52: Latin America Generative AI In Life Sciences Market Value Share (%), by Component, 2025
- Figure 53: Latin America Generative AI In Life Sciences Market Value (USD billion), by Deployment, 2025 & 2034
- Figure 54: Latin America Generative AI In Life Sciences Market Value Share (%), by Deployment, 2025
- Figure 55: Latin America Generative AI In Life Sciences Market Value (USD billion), by Technology 2025 & 2034
- Figure 56: Latin America Generative AI In Life Sciences Market Value Share (%), by Technology 2025
- Figure 57: Latin America Generative AI In Life Sciences Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 58: Latin America Generative AI In Life Sciences Market Value Share (%), by Product Type, 2025
- Figure 59: Latin America Generative AI In Life Sciences Market Value (USD billion), by Application, 2025 & 2034
- Figure 60: Latin America Generative AI In Life Sciences Market Value Share (%), by Application, 2025
- Figure 61: Latin America Generative AI In Life Sciences Market Value (USD billion), by End User, 2025 & 2034
- Figure 62: Latin America Generative AI In Life Sciences Market Value Share (%), by End User, 2025
- Figure 63: Latin America Generative AI In Life Sciences Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 64: Latin America Generative AI In Life Sciences Market Value Share (%), by Country/ Sub-region, 2025
- Figure 65: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by Component, 2025 & 2034
- Figure 66: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by Component, 2025
- Figure 67: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by Deployment, 2025 & 2034
- Figure 68: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by Deployment, 2025
- Figure 69: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by Technology 2025 & 2034
- Figure 70: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by Technology 2025
- Figure 71: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by Product Type, 2025 & 2034
- Figure 72: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by Product Type, 2025
- Figure 73: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by Application, 2025 & 2034
- Figure 74: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by Application, 2025
- Figure 75: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by End User, 2025 & 2034
- Figure 76: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by End User, 2025
- Figure 77: Middle East & Africa Generative AI In Life Sciences Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
- Figure 78: Middle East & Africa Generative AI In Life Sciences Market Value Share (%), by Country/ Sub-region, 2025
- Figure 79: Global Generative AI In Life Sciences Market Share (%), by Company, 2025
